Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Natural Products Day

This article was originally published in The Tan Sheet

Executive Summary

More than 350 people attended the Natural Products Association's "Natural Products Day" reception on Capitol Hill in Washington on March 27. The 10th annual event resulted in 160 lobbying appointments with senators and representatives, NPA says. In 2006 the trade group saw "several legislators signing onto bills" NPA supported following its lobbying day on Capitol Hill, a spokesperson says, and the group expects similar results this year. On the same day, the Dietary Supplement Education Alliance hosted an educational luncheon titled "Nutritional Supplements: Improving Lives, Saving Health Care Dollars" for members of Congress and the supplement industry. The luncheon earned a "Dear Colleague" letter from four members of Congress describing the importance of the event, DSEA says...

You may also be interested in...



Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.

Deal Watch: Novo Nordisk, Fauna To Explore Hibernation To Treat Obesity

A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.

Topics

UsernamePublicRestriction

Register

PS100358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel